European agency defends existing advice on later generation contraceptive pills

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f279 (Published 14 January 2013)
Cite this as: BMJ 2013;346:f279

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Sophie Arie
  1. 1London

France has called for a Europe-wide change in how later generation oral contraceptives are prescribed, because of the risk of side effects, but the European Medicines Agency has said that so far there is no new evidence to justify additional regulations.

At a press conference on Friday France’s health minister, Marisol Touraine, said that she would ask the agency to “modify” its market authorisation for third and fourth generation contraceptive pills. She also called for clearer warnings to be provided about the risks of venous embolism associated with the newer pills.

“The objective is that these pills are no longer …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL